He remdesivir, an antiviral medicine that prevents the virus from replicating in the body, was converted this Thursday, June 25 by recommendation of the European Medicines Agency (EMA, for its acronym in English) in the first drug indicated in the Old Continent to treat patients with covid-19 in serious condition. The first drug to treat coronavirus is approved in Europe.
The indication of this drug is currently limited to adults and adolescents from twelve years old who present pneumonia and require a supplemental supply of oxygen.
First drug to treat coronavirus approved in Europe
The final authorization for the use of the remdesivir still depends on the decision of the European Comission, who will rule on it next week.
The use of this antiviral to combat the coronavirus It is mainly supported by the preliminary results of a study published last Friday, May 22 in the New England Journal of Medicine (NEJM), which concludes that this medicine can reduce the lethality of the virus in a proportion of between 7% and 12% to that in serious patients, and promotes an earlier recovery of the sick.
The EMA has also considered a recommendation of the Committee for Medicinal Products for Human Use (CHMP), with which he shares the same criteria in the clinical indication of remdesivir.
In Europe The use of any specific anti-HIV drug had not yet been approved. coronavirus. Health professionals have hitherto combat the disease by resorting to various drugs, such as dexamethasone o go monoclonal antibodies.
MORE NEWS FROM COLOMBIA AND THE WORLD, HERE
You may also be interested in:
– .
